Literature DB >> 19564872

Differential contribution of genetic variation in multiple brain nicotinic cholinergic receptors to nicotine dependence: recent progress and emerging open questions.

L Greenbaum1, B Lerer.   

Abstract

Nicotine dependence (ND), a major public health challenge, is a complex, multifactorial behavior, in which both genetic and environmental factors have a role. Brain nicotinic acetylcholine receptor (nAChR)-encoding genes are among the most prominent candidate genes studied in the context of ND, because of their biological relevance as binding sites for nicotine. Until recently, most research on the role of nAChRs in ND has focused on two of these genes (encoding the alpha4- and beta2-subunits) and not much attention has been paid to the possible contribution of the other nine brain nAChR subunit genes (alpha2-alpha3, alpha5-alpha7, alpha9-alpha10, beta3-beta4) to the pathophysiology and genetics of ND. This situation has changed dramatically in the last 2 years during which intensive research had addressed the issue, mainly from the genetics perspective, and has shown the importance of the CHRNA5-CHRNA3-CHRNB4 and CHRNA6-CHRNB3 loci in ND-related phenotypes. In this review, we highlight recent findings regarding the contribution of non-alpha4/beta2-subunit containing nAChRs to ND, based on several lines of evidence: (1) human genetics studies (including linkage analysis, candidate-gene association studies and whole-genome association studies) of several ND-related phenotypes; (2) differential pharmacological and biochemical properties of receptors containing these subunits; (3) evidence from genetically manipulated mice; and (4) the contribution of nAChR genes to ND-related personality traits and neurocognitive profiles. Combining neurobiological genetic and behavioral perspectives, we suggest that genetic susceptibility to ND is not linked to one or two specific nAChR subtype genes but to several. In particular, the alpha3, alpha5-6 and beta3-4 nAChR subunit-encoding genes may play a much more pivotal role in the neurobiology and genetics of ND than was appreciated earlier. At the functional level, variants in these subunit genes (most likely regulatory) may have independent as well as interactive contributions to the ND phenotype spectrum. We address methodological challenges in the field, highlight open questions and suggest possible pathways for future research.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19564872     DOI: 10.1038/mp.2009.59

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  29 in total

1.  Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes.

Authors:  Allison B Gold; Caryn Lerman
Journal:  Hum Genet       Date:  2012-01-31       Impact factor: 4.132

2.  CHRNB2 promoter region: association with subjective effects to nicotine and gene expression differences.

Authors:  N R Hoft; J A Stitzel; K E Hutchison; M A Ehringer
Journal:  Genes Brain Behav       Date:  2010-11-04       Impact factor: 3.449

Review 3.  From smoking to lung cancer: the CHRNA5/A3/B4 connection.

Authors:  M R D Improgo; M D Scofield; A R Tapper; P D Gardner
Journal:  Oncogene       Date:  2010-06-28       Impact factor: 9.867

4.  Effect of neuronal nicotinic acetylcholine receptor genes (CHRN) on longitudinal cigarettes per day in adolescents and young adults.

Authors:  Dale S Cannon; Robin J Mermelstein; Donald Hedeker; Hilary Coon; Edwin H Cook; William M McMahon; Cindy Hamil; Diane Dunn; Robert B Weiss
Journal:  Nicotine Tob Res       Date:  2013-08-13       Impact factor: 4.244

5.  Association of the calcyon neuron-specific vesicular protein gene (CALY) with adolescent smoking initiation in China and California.

Authors:  Dalin Li; Stephanie J London; Jinghua Liu; Wonho Lee; Xuejuan Jiang; David Van Den Berg; Andrew W Bergen; Denise Nishita; Nahid Waleh; Gary E Swan; Peggy Gallaher; Chih-Ping Chou; Jean C Shih; Jennifer B Unger; W James Gauderman; Frank Gilliland; C Anderson Johnson; David V Conti
Journal:  Am J Epidemiol       Date:  2011-03-16       Impact factor: 4.897

6.  Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk.

Authors:  Catherine A Wassenaar; Qiong Dong; Qingyi Wei; Christopher I Amos; Margaret R Spitz; Rachel F Tyndale
Journal:  J Natl Cancer Inst       Date:  2011-07-11       Impact factor: 13.506

7.  The CHRNA5/A3/B4 gene cluster and tobacco, alcohol, cannabis, inhalants and other substance use initiation: replication and new findings using mixture analyses.

Authors:  Gitta H Lubke; Sarah H Stephens; Jeffrey M Lessem; John K Hewitt; Marissa A Ehringer
Journal:  Behav Genet       Date:  2012-03-01       Impact factor: 2.805

8.  Physiological effects of cigarette smoking in the limbic system revealed by 3 tesla magnetic resonance spectroscopy.

Authors:  Angelika Mennecke; Andrea Gossler; Thilo Hammen; Arnd Dörfler; Andreas Stadlbauer; Julie Rösch; Johannes Kornhuber; Stefan Bleich; Marc Dölken; Norbert Thürauf
Journal:  J Neural Transm (Vienna)       Date:  2014-03-19       Impact factor: 3.575

9.  Familial aggregation of tobacco use behaviors among Amish men.

Authors:  Katie L Nugent; Amber Million-Mrkva; Joshua Backman; Sarah H Stephens; Robert M Reed; Peter Kochunov; Toni I Pollin; Alan R Shuldiner; Braxton D Mitchell; L Elliot Hong
Journal:  Nicotine Tob Res       Date:  2014-02-28       Impact factor: 4.244

10.  Scientific overview: 2013 BBC plenary symposium on tobacco addiction.

Authors:  M De Biasi; I McLaughlin; E E Perez; P A Crooks; L P Dwoskin; M T Bardo; P R Pentel; D Hatsukami
Journal:  Drug Alcohol Depend       Date:  2014-06-02       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.